Literature DB >> 10668731

Spinal cord astrocytoma: response to PCV chemotherapy.

J W Henson1, A F Thornton, D N Louis.   

Abstract

Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10668731     DOI： 10.1212/wnl.54.2.518

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  5 in total

1.  Intramedullary Spinal Cord Tumors.

Authors:  Daniel C. Bowers; Bradley E. Weprin
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

Review 2.  Ependymomas.

Authors:  Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

3.  Ependymomas.

Authors:  Sajeel Chowdhary; Myke R Green; Marc Chamberlain
Journal:  Curr Treat Options Neurol       Date:  2006-07       Impact factor: 3.972

Review 4.  Primary Spinal Astrocytomas: A Literature Review.

Authors:  John Ogunlade; James G Wiginton; Christopher Elia; Tiffany Odell; Sanjay C Rao
Journal:  Cureus       Date:  2019-07-26

5.  Chemotherapy for adult patients with spinal cord gliomas.

Authors:  Dorothee Gramatzki; Jörg Felsberg; Bettina Hentschel; Oliver Bähr; Manfred Westphal; Gabriele Schackert; Jörg Christian Tonn; Ulrich Herrlinger; Markus Loeffler; Torsten Pietsch; Joachim Peter Steinbach; Guido Reifenberger; Patrick Roth; Michael Weller
Journal:  Neurooncol Pract       Date:  2021-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.